亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北武漢遠成藥業責任有限公司  

原料藥,醫藥中間體,食品添加劑

搜索
新聞中心
產品分類
  • 暫無分類
聯系方式
  • 聯系人:吳翠娥
  • 電話:027-59262863
  • 郵件:912941322@qq.com
  • 傳真:027-88048077
  • QQ:912941322
站內搜索
 
榮譽資質
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 硝酸異康唑
硝酸異康唑
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2012-03-23 18:07
 
詳細信息


硝酸異康唑

醫藥級硝酸異康唑/24168-96-5
中文別名: 硝酸鄰氯益康唑 
英文名稱: isoconazole nitrate
英文別名: 
CAS號: 24168-96-5
EINECS號: 246-051-4
分子式: C18H14Cl4N2O·HNO3;C18H15 
分子量: 479.15 
InChI: InChI=1/C18H14Cl4N2O.HNO3/c19-12-4-5-13(17(22)8-12)18(9-24-7-6-23-11-24)25-10-14-15(20)2-1-3-16(14)21;2-1(3)4/h1-8,11,18H,9-10H2;(H,2,3,4) 
分子結構:  
熔點: 178-182℃ 
 

硝酸異康唑產品用途:
屬廣譜抗真菌藥 
 
 以上是硝酸異康唑的詳細信息,如果您對硝酸異康唑的價格、廠家、級別、含量、圖片有什么疑問,請聯系我們獲取硝酸異康唑的最新信息

©2025 湖北武漢遠成藥業責任有限公司 版權所有   技術支持:化工網   訪問量:21194  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |